Diagnostic test for ovarian cancer

Thursday, 01 January, 2009 | Supplied by: Manalto Inc

The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.

The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.

Results are available within a fortnight.

Online: www.healthlinx.com.au
Phone: 03 9208 4200

Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium

The products provide researchers and manufacturers with high-performance, scalable and...

Grace Bio-Labs protein microarray tools

Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...

Siemens Healthineers 3gAllergy assay

Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...

Content from other channels on our network

Australians use more water than we think

Switchgear tech receives sustainable design award

Partnership to turn cooking oil into fuel

Why Australia's AI ambitions depend on smarter networks

Nanofiltration membrane tech removes pharma pollution

Mondi develops lighter banana box

Food quality testing laboratory being opened in Victoria

Getting the right balance of water content in butter

What's on trend in the food supplements & nutrition market?

New standard for edible bird's nest products

Transforming the treatment experience: Rānui Apartments, New Zealand

Nurse-led regional clinics pilot shows promise

Reusing medical equipment is good for the planet. But is it safe?

Benefits of modern hybrid multicloud platforms in health care

Faster acute kidney injury test in development